Growth and Revenue Covalon reports substantial top-line potential with annual revenue in the hundred millions range and recent quarterly growth driven by all sales channels, signaling opportunities to expand into higher-volume contracts, multi-site hospital systems, or regional distributors.

Wound Care Leadership Strong focus on advanced wound care and infection prevention presents cross-sell potential across care settings, including hospitals, long-term care, and outpatient clinics seeking skin integrity and HAIs reduction solutions.

Vascular Access Expansion VALGuard vascular access line protection research and productライン indicate a chance to target interventional suites and anesthesia bays with bundled solutions for line security, reducing procedural complications and related costs.

Strategic Partnerships Recent board changes, executive leadership updates, and participation in microcap showcases suggest an openness to strategic partnerships and collaborations with distributors, contract manufacturers, and capital access for scaling.

Global and Public Market Access Public listings on TSXV and OTCQX, combined with multinational exposure, create avenues to approach institutional buyers and large healthcare networks seeking validated medical device partners with proven revenue growth and regulatory readiness.